Rick Barber

Partner

Zal Bilimoria

Founding Partner

David Lee

Co-Founder

78 past transactions

Cofactor Genomics, Inc.

Series A in 2017
Cofactor Genomics is a Predictive Immune Modeling company driven to remove the barriers that have prohibited the advancement of true precision medicine. Cofactor is enabling the industry to move beyond isolated, single-analyte biomarkers to powerful multidimensional biomarkers using Health Expression Models. Through their molecular, informatic, and database tools, and one of the first CAP-certified, clinical RNA sequencing laboratories, Cofactor enables their partners to deliver more expedient, cost effective, and successful clinical trials.

Orchid

Seed Round in 2021
Orchid is a reproductive technology startup that is capable of detecting rare genetic disorders. Orchid’s preconception system analyzes both partners’ genomes and assesses genetic predispositions to common diseases, including heart disease, stroke, schizophrenia, Alzheimer’s disease, breast cancer, and diabetes. Orchid results are developed with world-class experts in reproductive medicine and genetics to give its clients the most accurate results. Orchid offers a “Couple Report” that utilizes an at-home saliva test to analyze each person’s genomes to detect the probability of genetic risks, then models how their DNA together will combine in a future child. If elevated risk is detected, Orchid provides insights to help couples monitor biomarkers, adapt their diet or elect for procedures, such as in vitro fertilization. It was founded by Noor Siddiqui in 2019 and is headquartered in San Francisco, California.

Brave Care, Inc.

Series A in 2021
Brave Care, Inc. offers urgent pediatric health care services. It provides treatment for allergies, asthma, cough and whooping cough, ear pain, eye problems, fever, light sedation for painful procedures, minor fracture care, minor head trauma, pediatric specific laboratory services, pediatric specific on-site x-ray, rashes, stitches, sore throats, sports physicals, stomach aches, strains and sprains, tissue glue wound closure, and urinary tract infection. The company was founded in 2019 and is based in Portland, Oregon.

Biobot Analytics

Seed Round in 2018
Biobot Analytics is a wastewater epidemiology company that is transforming wastewater infrastructure into public health observatories. Its wastewater monitoring technology analyzes urine and stool samples to create a health database that is independent of hospital reporting systems, free from societal biases affecting who can and can’t seek care, and most importantly, rapidly adaptable to new and emerging public health threats.

Knowde

Series B in 2021
knowde is the online marketing platform dedicated to chemicals and ingredients. They make it easy to connect with customers, online. Use knowde Pages to get your products noticed every time a customer searches on any search engine. Build your knowde Page in an hour and get started for free.

PathAI

Seed Round in 2016
PathAI, Inc. develops artificial intelligence-based technology solutions for pathology laboratories. It develops a technology that assists pathologists in making rapid and accurate diagnoses for patients. The company also builds solutions to help identify patients that benefit from novel therapies, to make scalable personalized medicine a reality. PathAI, Inc. was founded in 2016 and is based in Boston, Massachusetts with an additional office in Austin, Texas.

Mythic Therapeutics

Series B in 2021
Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics. The company is pioneering a powerful protein engineering-focused approach to improving the effectiveness of antibody-drug conjugates (ADCs) and other antibody-based therapeutics. Their technology dramatically increases therapeutic potency without compromising safety, thereby unlocking the full potential of targeted therapies against a broad array of tumor targets. Mythic Therapeutics was founded in 2017 and is headquartered in Waltham, MA, USA.

PathAI

Series A in 2017
PathAI, Inc. develops artificial intelligence-based technology solutions for pathology laboratories. It develops a technology that assists pathologists in making rapid and accurate diagnoses for patients. The company also builds solutions to help identify patients that benefit from novel therapies, to make scalable personalized medicine a reality. PathAI, Inc. was founded in 2016 and is based in Boston, Massachusetts with an additional office in Austin, Texas.

Blockfolio, Inc.

Series A in 2018
Blockfolio offers mobile portfolio tracking and management for the cryptocurrency and blockchain industry. Blockfolio is the network for mobile cryptocurrency portfolio tracking and management. Millions of people trust Blockfolio to stay connected to the pulse of the industry through market data, news, and direct updates from leaders of top crypto projects. Blockfolio is committed to providing free access to our users and token team partners.

Solugen

Series C in 2021
Solugen is a specialty chemicals ​manufacturer creating chemistries that are safe, cost-effective, and environmentally-friendly. The company manufactures and supplies of registered biocides and specialty bio-based solutions for divalent control in process flow assurance and asset integrity. Solugen's patented approach takes advantage of bio-inspired reactions to use plant material as a low-cost feedstock to produce novel products cost-competitive with the competition.

Orchid

Seed Round in 2021
Orchid is a reproductive technology startup that is capable of detecting rare genetic disorders. Orchid’s preconception system analyzes both partners’ genomes and assesses genetic predispositions to common diseases, including heart disease, stroke, schizophrenia, Alzheimer’s disease, breast cancer, and diabetes. Orchid results are developed with world-class experts in reproductive medicine and genetics to give its clients the most accurate results. Orchid offers a “Couple Report” that utilizes an at-home saliva test to analyze each person’s genomes to detect the probability of genetic risks, then models how their DNA together will combine in a future child. If elevated risk is detected, Orchid provides insights to help couples monitor biomarkers, adapt their diet or elect for procedures, such as in vitro fertilization. It was founded by Noor Siddiqui in 2019 and is headquartered in San Francisco, California.

Uniform Teeth

Series A in 2019
Uniform Teeth is an orthodontics practice committed to making orthodontic care as intuitive, accessible, and high quality as possible. Uniform Teeth specializes in providing clear straighteners.

Knowde

Seed Round in 2018
knowde is the online marketing platform dedicated to chemicals and ingredients. They make it easy to connect with customers, online. Use knowde Pages to get your products noticed every time a customer searches on any search engine. Build your knowde Page in an hour and get started for free.

Phytoform Labs

Seed Round in 2021
Phytoform Labs is a biotechnology company which aims to help breeders to cut down plant breeding times from decades to years using new gene editing technologies. Predictably evolving plants will maximise yields for breeders and improve the economics of breeding for customers.

Cofactor Genomics, Inc.

Series A in 2017
Cofactor Genomics is a Predictive Immune Modeling company driven to remove the barriers that have prohibited the advancement of true precision medicine. Cofactor is enabling the industry to move beyond isolated, single-analyte biomarkers to powerful multidimensional biomarkers using Health Expression Models. Through their molecular, informatic, and database tools, and one of the first CAP-certified, clinical RNA sequencing laboratories, Cofactor enables their partners to deliver more expedient, cost effective, and successful clinical trials.

Uniform Teeth

Series A in 2019
Uniform Teeth is an orthodontics practice committed to making orthodontic care as intuitive, accessible, and high quality as possible. Uniform Teeth specializes in providing clear straighteners.

Ophelia

Series B in 2021
Ophelia offers medication and support for quitting opioids. They are a diverse collection of hearts and minds - doctors, scientists, techies, and citizens - on a mission to offer the best of medicine without the baggage of rehab. They are driven by science, committed to privacy, and bound to the client's right to make their own choices. They believe in recommendations, not orders. It was founded in 2019 and is based in Philadelphia, Pennsylvania.

Cambridge Crops, Inc.

Series B in 2022
Mori is a developer of an edible and natural biomaterial coating that extends the shelf life of perishable foods. It uses salt and water to extract the protein from natural silk and creates a protective layer that keeps food fresher for longer enabling it to economically and sustainably transform the food supply by developing and commercializing technologies for the food, agriculture, and packaging industries. It was founded in 2016 by Adam Behrens and is headquartered in Boston, Massachusetts.

Clover Health

Series D in 2017
Clover Health is a provider of Medicare Advantage health plans to older Americans. The company operates a Preferred Provider Organization (PPO) platform to improve the quality of life of its members and physicians. Its platform utilizes patient-centered analytics and a dedicated care management team to identify potential risks and directly provide preventive care, thereby enabling patients and their health care providers to reduce avoidable spending as well as identify and manage chronic diseases. Clover uses sophisticated analytics and custom software to direct its own clinical staff to proactively fill in gaps in the care of its members.

Brave Care, Inc.

Seed Round in 2019
Brave Care, Inc. offers urgent pediatric health care services. It provides treatment for allergies, asthma, cough and whooping cough, ear pain, eye problems, fever, light sedation for painful procedures, minor fracture care, minor head trauma, pediatric specific laboratory services, pediatric specific on-site x-ray, rashes, stitches, sore throats, sports physicals, stomach aches, strains and sprains, tissue glue wound closure, and urinary tract infection. The company was founded in 2019 and is based in Portland, Oregon.

64-x

Series A in 2022
64-x designs microorganisms with enhanced properties that enable otherwise unattainable applications in biomanufacturing, bioremediation, and health. Alexis Rovner, George Church, Jeffrey Way, and Pamela Silver founded 64-x on August 22, 2017. 64-x is based in San Francisco, CA.

Avail Medsystems

Series A in 2020
Avail Medsystems, Inc. develops software that remotely connects health care experts to practitioners. Its platform provides procedural support, observation, and clinical education services to healthcare organizations. Avail Medsystems, Inc. was formerly known as Nurep, Inc. and changed its name to Avail Medsystems, Inc. in March 2018. The company was incorporated in 2012 and is based in Palo Alto, California.

Cambridge Crops, Inc.

Series B in 2021
Mori is a developer of an edible and natural biomaterial coating that extends the shelf life of perishable foods. It uses salt and water to extract the protein from natural silk and creates a protective layer that keeps food fresher for longer enabling it to economically and sustainably transform the food supply by developing and commercializing technologies for the food, agriculture, and packaging industries. It was founded in 2016 by Adam Behrens and is headquartered in Boston, Massachusetts.

FYTO, Inc

Series A in 2022
FYTO provides innovative solutions which improve the economic and environmental sustainability of agriculture for farmers around the world. FYTO is developing: NOVEL NUTRIENT-DENSE CROPS that have ultra-high yields and ultra-low resource requirements, STATE-OF-THE ART CULTIVATION AND HARVESTING SYSTEMS for exceptional quality and consistency, CLIMATE-FRIENDLY METHODOLOGIES for resiliency and long-term sustainability, and a range of GROUNDBREAKING AGRICULTURAL PRODUCTS such as animal feed and biofertilizer.

Shield Bio

Seed Round in 2017
At Shield, we’re ensuring that antibiotic resistance doesn’t become more deadly than cancer. In 2050 more people will be dying of antibiotic resistant pathogens than cancer. Infections that were once treatable with a simple oral antibiotics are now requiring complex, painful treatments and resulting in serious health complications for patients. Gonorrhea is one such infection, having become resistant to over 10 different antibiotics, they have only one treatment that is still effective and resistance to this has already begun to emerge. With 820,000 new infections every year in the US, antibiotic resistance will spread quickly, which is why the CDC has resistant gonorrhea at an urgent threat level, the highest level available. Shield's novel genomic testing platform enables STI clinics to identify the antibiotic resistant strains of gonorrhea and other pathogens that their patients have, so they can select the correct antibiotics and halt the spread of antibiotic resistance.

Solugen

Series C in 2021
Solugen is a specialty chemicals ​manufacturer creating chemistries that are safe, cost-effective, and environmentally-friendly. The company manufactures and supplies of registered biocides and specialty bio-based solutions for divalent control in process flow assurance and asset integrity. Solugen's patented approach takes advantage of bio-inspired reactions to use plant material as a low-cost feedstock to produce novel products cost-competitive with the competition.

64-x

Seed Round in 2020
64-x designs microorganisms with enhanced properties that enable otherwise unattainable applications in biomanufacturing, bioremediation, and health. Alexis Rovner, George Church, Jeffrey Way, and Pamela Silver founded 64-x on August 22, 2017. 64-x is based in San Francisco, CA.

Ophelia

Series A in 2021
Ophelia offers medication and support for quitting opioids. They are a diverse collection of hearts and minds - doctors, scientists, techies, and citizens - on a mission to offer the best of medicine without the baggage of rehab. They are driven by science, committed to privacy, and bound to the client's right to make their own choices. They believe in recommendations, not orders. It was founded in 2019 and is based in Philadelphia, Pennsylvania.

Curative Inc.

Seed Round in 2020
Curative provide communities with 24-hour COVID-19 testing at scale with a significantly more efficient and precise oral fluid test that reduces pressure on medical supply chains and healthcare workers.
YourChoice Therapeutics, Inc. develops and manufactures non-hormonal contraceptive product for women. The company develops a technology with active compound which inhibits sperm motility and prevents sperm from fertilizing the egg. YourChoice Therapeutics, Inc. was founded in 2018 and is headquartered in Berkeley, California.
Astranis is a developer of a new satellite technology that aims to transmit data down to specific terrestrial locations with each satellite it launches. The company's mission is to help get online the 4 billion people who are without internet access.

Finova Financial LLC

Seed Round in 2016
Finova Financial LLC develops and operates digital financial services technology platform, provides consumer loan on cars. The company was founded in 2015 and is based in Palm Beach Gardens, Florida.

PathAI

Series C in 2021
PathAI, Inc. develops artificial intelligence-based technology solutions for pathology laboratories. It develops a technology that assists pathologists in making rapid and accurate diagnoses for patients. The company also builds solutions to help identify patients that benefit from novel therapies, to make scalable personalized medicine a reality. PathAI, Inc. was founded in 2016 and is based in Boston, Massachusetts with an additional office in Austin, Texas.

Uniform Teeth

Seed Round in 2018
Uniform Teeth is an orthodontics practice committed to making orthodontic care as intuitive, accessible, and high quality as possible. Uniform Teeth specializes in providing clear straighteners.

Culture Robotics

Venture Round in 2019
Culture Biosciences develops automated bio-reactor that helps biotech companies optimize their manufacturing processes and brings products to market faster. The company also builds automated tools for fermentation. It has a digital bio-manufacturing platform to enable scientists to run, monitor, and analyze bio-reactors faster than traditional approaches by robotic sample handling and cloud data monitoring and analysis. Culture Biosciences was founded in 2016 and is headquartered in San Francisco, California.

Kin Euphorics

Venture Round in 2019
Kin Euphorics offers an adult beverage made from nourishing nootropics, balancing adaptogens, and replenishing botanics. The New York-based company was founded in 2017.

Headspace, Inc.

Series A in 2015
Headspace is a digital health platform that provides guided meditation sessions and mindfulness training. With hundreds of hours of content, it is acknowledged as one of the most comprehensive secular programs for meditation and mindfulness. Its health application can be downloaded in mobiles and tablets that provide mindfulness and mental training through health videos and chat options, enabling users and companies to access free meditation sessions and mindfulness training. It was founded in 2010 and is headquartered in Santa Monica, California.

Octant Bio

Seed Round in 2017
Octant, Inc. engages in engineering biology to design multi-targeted small molecule drug leads for complex diseases. Its polypharmacology discovery engine generates multi-receptor pathway data and predictive insights to inform rational drug design. The company also engineers biology using living cells as high-throughput signal networks to map, measure, and model chemical structures against G protein-coupled receptors (GPCRs). The company was incorporated in 2017 and is headquartered in Los Angeles, California.

Checkerspot

Seed Round in 2018
Checkerspot, Inc., a biotech company, produces performance materials using microalgae. The company was founded in 2016 and is based in Berkeley, California.

Solugen

Series A in 2018
Solugen is a specialty chemicals ​manufacturer creating chemistries that are safe, cost-effective, and environmentally-friendly. The company manufactures and supplies of registered biocides and specialty bio-based solutions for divalent control in process flow assurance and asset integrity. Solugen's patented approach takes advantage of bio-inspired reactions to use plant material as a low-cost feedstock to produce novel products cost-competitive with the competition.

Alloy Technologies, Inc.

Seed Round in 2016
Alloy is a purpose-built platform enabling consumer goods companies to evaluate, predict, and respond to true demand with agility and efficiency. With Alloy, brands can analyze sales and inventory at both macro and micro levels, down to the individual store and SKU, to accelerate sales insights, drive future growth, and optimize the supply chain. A breadth of customers have benefited from the end-to-end insight into their business, ranging from Fortune 100 enterprises to fast-growing startups like eero, Walker & Company, and Soludos.

Ophelia

Seed Round in 2020
Ophelia offers medication and support for quitting opioids. They are a diverse collection of hearts and minds - doctors, scientists, techies, and citizens - on a mission to offer the best of medicine without the baggage of rehab. They are driven by science, committed to privacy, and bound to the client's right to make their own choices. They believe in recommendations, not orders. It was founded in 2019 and is based in Philadelphia, Pennsylvania.

Hero

Series A in 2018
Hero is the first and only in-home medication manager that intuitively sorts and dispenses medication; has audible and digital reminders; automates refills; and provides real-time as well as historical adherence data at your fingertips. Hero was founded to be the world's most people-focused healthcare company by creating frictionless solutions to the most challenging problems facing patients and caregivers.

FactoryFour

Series A in 2018
Manufacturing execution system rebuilt around a modern technology stack. No more inflexible systems, endless implementations, and ridiculous fees for bad software. Experience highly customizable, simple to use, and quick to deploy manufacturing management solutions that increase predictability, productivity, and profit.

Solugen

Seed Round in 2017
Solugen is a specialty chemicals ​manufacturer creating chemistries that are safe, cost-effective, and environmentally-friendly. The company manufactures and supplies of registered biocides and specialty bio-based solutions for divalent control in process flow assurance and asset integrity. Solugen's patented approach takes advantage of bio-inspired reactions to use plant material as a low-cost feedstock to produce novel products cost-competitive with the competition.

Kip Labs, Inc.

Seed Round in 2016
Kip combines traditional in-person therapy with a private app so that you get the most out of every session. Meet your therapist in person and start working on your personalized care plan. Share daily thoughts, feelings, and events with your therapist on Kip's private app. Achieve measurable results with Kip's science-backed, results-driven approach. Not your average therapy service, Kip makes therapy more effective by combining in-person visits with digital support in-between.

Clover Health

Series C in 2016
Clover Health is a provider of Medicare Advantage health plans to older Americans. The company operates a Preferred Provider Organization (PPO) platform to improve the quality of life of its members and physicians. Its platform utilizes patient-centered analytics and a dedicated care management team to identify potential risks and directly provide preventive care, thereby enabling patients and their health care providers to reduce avoidable spending as well as identify and manage chronic diseases. Clover uses sophisticated analytics and custom software to direct its own clinical staff to proactively fill in gaps in the care of its members.

Verge Genomics

Seed Round in 2015
Verge Genomics transforms drug discovery with artificial intelligence. Verge was founded by a unique combination of the field's top machine learning experts and seasoned neuroscience drug developers. Together, they share the vision that exponential advances in computational genomics combined with new insights into neuroscience has created a breakthrough opportunity to discover drugs that dramatically improve the lives of patients suffering from neurodegenerative disease.

Call9

Series A in 2016
Call9, Inc. develops a mobile technology platform for patients to connect to physicians. Its products include Call9 tele-EM platform, a technology platform that connects emergency physicians and clinical care specialists to deliver bedside emergency care to nursing home patients. It caters to businesses which have nurses or trained first aid staff and need support for medical emergencies. The company was incorporated in 2015 and is based in Brooklyn, New York.

Plutoshift

Seed Round in 2017
Plutoshift is an operational data platform to monitor physical infrastructure. It leverages existing data collection systems to automate data workflows and provide a unified view of performance. It was founded in 2017 and headquartered in Palo Alto, California.

Tempest, Inc.

Series A in 2019
Tempest, Inc. operates an online recovery school that offers a virtual course for people wanting to quit alcohol. It also offers email courses. It offers tools to help participants learn the importance of purpose, meaning, and creativity in living a life without alcohol. Tempest, Inc. was formerly known as Hip Sobriety, Inc. and changed its name to Tempest, Inc. in May 2019. The company founded in 2014 and is based in New York, New York.

Trace Genomics

Seed Round in 2016
Trace Genomics has developed the first analytics engine that learns as it maps the living soil. Founded in 2015 to serve the farming community, Trace Genomics helps growers maximize the value of every acre. The company is building the largest, most actionable body of soil intelligence, making thousands of growers experts on what’s underground. Working collaboratively across the agriculture ecosystem, Trace Genomics helps growers optimize costs, manage risk and protect their soil as a capital asset. Headquartered in Silicon Valley—and led by two female founders—Trace Genomics has raised $22 million in financing.

TL Biolabs Corp.

Seed Round in 2017
TL Biolabs Corp. operates as a biotechnology company that provides automated genomic testing for the livestock. The company was incorporated in 2016 and is based in Santa Clara, California.

Redesign Science

Seed Round in 2019
They efficiently simulate protein targets at the atomic level to reveal hidden, subtle drug opportunities that fall outside the capability and scope of alternative computational models.Basic science is proliferating with new understanding of biological pathways and disease mechanisms. New technologies are needed to solve emerging challenges and to commercialize new opportunities.
Astranis is a developer of a new satellite technology that aims to transmit data down to specific terrestrial locations with each satellite it launches. The company's mission is to help get online the 4 billion people who are without internet access.

Umbrella, Inc.

Seed Round in 2019
Umbrella provides a task management platform intended to connect senior citizens with workers to do small temporary jobs around the house. The company's platform connects users with community members to help with everyday home chores and maintenance and handles tasks like carpentry, changing light bulbs and light fixtures, fixing leaky faucets, assembling furniture, cleaning gutters, hanging picture frames, installing grab bars, installing and removing air conditioners and unclogging drains, enabling seniors to stay and live in their own homes happily.

Finova Financial LLC

Venture Round in 2016
Finova Financial LLC develops and operates digital financial services technology platform, provides consumer loan on cars. The company was founded in 2015 and is based in Palm Beach Gardens, Florida.

Cambridge Crops, Inc.

Series A in 2020
Mori is a developer of an edible and natural biomaterial coating that extends the shelf life of perishable foods. It uses salt and water to extract the protein from natural silk and creates a protective layer that keeps food fresher for longer enabling it to economically and sustainably transform the food supply by developing and commercializing technologies for the food, agriculture, and packaging industries. It was founded in 2016 by Adam Behrens and is headquartered in Boston, Massachusetts.

PicnicHealth

Seed Round in 2015
PicnicHealth is all about making medical records easy to access and using data to power the next frontier of medical research. We’re led by the belief that there’s power in medical information when it’s used well, and that every person has a right to their own theirs. And we've built award-winning machine learning to do it. How? PicnicHealth works directly with patients to give them the only tool anywhere that truly provides all of their medical records from any doctor or healthcare system in the US—in an easy-to-use, secure online dashboard. Not only that, but patients can choose to contribute their data to scientific research, which helps life sciences researchers accelerate breakthroughs in care. Researchers use this anonymized “real-world data” to understand how diseases are experienced by patients and treated by clinicians in the real world, going beyond the highly controlled setting of clinical trials. The goal is to create better treatments that can ultimately improve outcomes for patients. Whether you’re a scientist, engineer, or patient yourself, we’re looking for passionate people to join us in redefining an industry during our next stage of growth. To date we’ve helped tens of thousands of patients, partnered with some of the world’s largest biopharma companies, and raised more than $35M from Felicis Ventures, Amplify Partners, Foresite Capital, Refactor Capital, and Y Combinator.

Solugen

Series B in 2019
Solugen is a specialty chemicals ​manufacturer creating chemistries that are safe, cost-effective, and environmentally-friendly. The company manufactures and supplies of registered biocides and specialty bio-based solutions for divalent control in process flow assurance and asset integrity. Solugen's patented approach takes advantage of bio-inspired reactions to use plant material as a low-cost feedstock to produce novel products cost-competitive with the competition.

Legalist

Seed Round in 2016
Legalist provides legal data analytics services designed to help small business to get access to the justice system. Its services help lawyers to track state trial cases, get e-mail alerts for cases and predict trial timelines before cases start, enabling plaintiffs and their attorneys to tackle legal situations and complications in a convenient and hassle-free manner.

Gencove

Seed Round in 2017
We make genomics affordable and accessible through a cost-effective low-coverage whole genome sequencing technology

Shield Bio

Series A in 2018
At Shield, we’re ensuring that antibiotic resistance doesn’t become more deadly than cancer. In 2050 more people will be dying of antibiotic resistant pathogens than cancer. Infections that were once treatable with a simple oral antibiotics are now requiring complex, painful treatments and resulting in serious health complications for patients. Gonorrhea is one such infection, having become resistant to over 10 different antibiotics, they have only one treatment that is still effective and resistance to this has already begun to emerge. With 820,000 new infections every year in the US, antibiotic resistance will spread quickly, which is why the CDC has resistant gonorrhea at an urgent threat level, the highest level available. Shield's novel genomic testing platform enables STI clinics to identify the antibiotic resistant strains of gonorrhea and other pathogens that their patients have, so they can select the correct antibiotics and halt the spread of antibiotic resistance.

Enzyme

Seed Round in 2017
Enzyme is building software to help life sciences companies with FDA approval and regulatory compliance. Using Enzyme’s software, those companies can avoid spending money on costly consultants which in turn can reduce their compliance costs by up to 50 percent. Since 10 percent of all personnel in biopharma and life sciences companies are related to regulatory issues, it can lower headcount as well. Perhaps most importantly, Enzyme can also make it easier and faster for those companies to bring their products to market.

ANA Therapeutics

Seed Round in 2020
ANA Therapeutics is a developer of a novel coronavirus vaccine intended to save human lives. It is developing therapeutics to solve the coronavirus pandemic using Niclosamide that enables medical practitioners to treat patients suffering from COVID-19. It was founded in 2020 and is headquartered in Foster City, California.

Cambridge Crops, Inc.

Seed Round in 2019
Mori is a developer of an edible and natural biomaterial coating that extends the shelf life of perishable foods. It uses salt and water to extract the protein from natural silk and creates a protective layer that keeps food fresher for longer enabling it to economically and sustainably transform the food supply by developing and commercializing technologies for the food, agriculture, and packaging industries. It was founded in 2016 by Adam Behrens and is headquartered in Boston, Massachusetts.
Cambridge Cancer Genomics Limited offers diagnostics tests for cancer patients using liquid biopsy, artificial intelligence, and genomics. It uses artificial neural networks and machine learning algorithms to design personalized tests for tracking treatment response in patients. The company enables cancer clinics, academic institutes, biotech startups, and pharmaceutical companies to make use of the tools and therapies. Cambridge Cancer Genomics Limited was incorporated in 2017 and is based in Cambridge, United Kingdom.

Alpha Health LLC

Seed Round in 2019
Alpha Health LLC develops a unified automation platform for Healthcare revenue cycle management. This enables health systems to reduce the cost of care. Its solution captures multimodal data to provide a 360-degree view of current workflows and processes. The company's platform identifies broken workflows and corrects them, often eliminating unnecessary work. Alpha Health LLC was founded in 2018 and is based in South San Francisco, California.

PathAI

Seed Round in 2016
PathAI, Inc. develops artificial intelligence-based technology solutions for pathology laboratories. It develops a technology that assists pathologists in making rapid and accurate diagnoses for patients. The company also builds solutions to help identify patients that benefit from novel therapies, to make scalable personalized medicine a reality. PathAI, Inc. was founded in 2016 and is based in Boston, Massachusetts with an additional office in Austin, Texas.

Knowde

Pre Seed Round in 2017
knowde is the online marketing platform dedicated to chemicals and ingredients. They make it easy to connect with customers, online. Use knowde Pages to get your products noticed every time a customer searches on any search engine. Build your knowde Page in an hour and get started for free.

Vital

Seed Round in 2019
Vital Software Inc. develops cloud-based emergency department software for hospitals and patients. Its software enables clinicians to reduce time on EHRs; optimizing flow with artificial intelligence; and integrated IT solutions. The company was founded in 2017 and is based in Atlanta, Georgia.

Call9

Series B in 2017
Call9, Inc. develops a mobile technology platform for patients to connect to physicians. Its products include Call9 tele-EM platform, a technology platform that connects emergency physicians and clinical care specialists to deliver bedside emergency care to nursing home patients. It caters to businesses which have nurses or trained first aid staff and need support for medical emergencies. The company was incorporated in 2015 and is based in Brooklyn, New York.

Knowde

Series A in 2020
knowde is the online marketing platform dedicated to chemicals and ingredients. They make it easy to connect with customers, online. Use knowde Pages to get your products noticed every time a customer searches on any search engine. Build your knowde Page in an hour and get started for free.
Astranis is a developer of a new satellite technology that aims to transmit data down to specific terrestrial locations with each satellite it launches. The company's mission is to help get online the 4 billion people who are without internet access.

Fortmatic Inc.

Seed Round in 2020
Get peace of mind with secure, extensible passwordless authentication that’s built to scale. All with a few lines of code.

Rubedo Life Sciences, Inc

Seed Round in 2020
Rubedo Life Sciences, Inc develops therapies targeting senescent cells which drive age-related diseases. The company offers ALEMBIC, a drug discovery platform, has generated a pipeline of therapeutic candidates which selectively target senescent cells, pro-inflammatory, and pro-fibrotic cell populations that result from a variety of cellular stress and damage bloodstream. Rubedo Life Sciences, Inc was incorporated in 2018 and is based in Sunnyvale, California.